Navigation Links
Avicena to Advance Huntington's Disease Clinical Program into Phase III

Avicena Group, Inc. (OTC Bulletin Board: AVGO), a late stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases, announced today the selection of the optimal dose of HD-02, its novel drug candidate for the treatment of Huntington's Disease.

This dose was determined in an open-label dose escalation study, led by Dr. Steven Hersch and Dr. Diana Rosas of Massachusetts General Hospital (MGH), and will be further evaluated in a Phase III clinical trial.

The dose escalation study evaluated HD-02 in a range of doses from 10 to 40 grams per day and successfully determined the optimal dose that provided the maximum efficacy, safety and tolerability. The full scope of the data will be disseminated upon the results being peer reviewed.

Based on these findings, Avicena and its collaborators Dr. Hersch and the Huntington Study Group have developed a double-blind, placebo-controlled Phase III clinical trial anticipated to commence in early 2008. The Phase III trial will be one of the single largest trials for Huntington's patients, with external funding to be announced.

Upon commencement of this clinical trial, Avicena will have advanced three different indications into phase III trials that include some of the largest trial to date in both Parkinson's and Huntington's.

"We are very encouraged by the results of our HD-02 trial and we believe that in conjunction with our collaborators at MGH, we have identified the optimal dose as we move forward to validate HD-02 as a potential treatment for Huntington's disease, for which there is no current approved drug by the FDA.

We are committed to developing therapeutics that we hope can slow the progression of neurodegenerative diseases," stated Belinda Tsao-Nivaggioli, CEO of Avicena.

"We are excited by the results of our studies with HD-02 to date. This Phase III study will evaluat
'"/>




Page: 1 2

Related medicine news :

1. Advances in Treatment of Cataracts
2. Advanced STD programs required
3. Hope For Patients With Advanced Breast Cancer
4. Advances In Stem Cells Research
5. Breast Cancer Advance
6. Canadian Lung Cancer Study Lauded As Major Advance in Cancer Fight
7. Speedier Access To Advances In Breast Cancer Sought For Patients
8. HIV Vaccine Field Trials In Advanced Stage
9. Advance Funeral For AIDS-infected South African
10. New Screening Techniques to Lead Advances In Pain Therapy
11. Twin Treatment Could Be Used Increase Survival Rates In Advanced Melanoma
Post Your Comments:
(Date:9/20/2014)... (PRWEB) September 20, 2014 David Cooke ... 2014. The first poster looked at the clinical benefits ... cycle for calculating diastolic function. In conjunction with colleagues ... renal disease and normal LVEF by echo (>50%). Each ... protocol, and standard SPECT. Emory Toolbox 4.0 ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 The Villa ... Villa del Palmar Cabo San Lucas, Villa La Estancia ... to Hurricane Odile, with plans to welcome guests back ... As of Sept. 19, all members and guests of ... thanks to a coordinated effort with government authorities. ...
(Date:9/20/2014)... Mexico (PRWEB) September 20, 2014 Villa ... the resort did not experience any damage in relation ... amenities and activities available. , Hurricane Odile struck Cabo ... intense wind, rain and powerful surf conditions. Located on ... Palmar Islands of Loreto experienced some heavy rain, but ...
(Date:9/20/2014)... Increases in household, construction and ... treatment volumes. However, government regulations and higher landfill ... According to IBISWorld industry analyst Alen Allday, “over ... at reducing the volume of waste generated, and ... Still, a large proportion of waste generated by ...
(Date:9/20/2014)... Ticket Down is a dependable source for ... ticket exchange is offering their customer appreciation promo code ARIANA-2015 ... tours is beginning to fill up. Many of the biggest ... the road, including 21-year-old pop superstar, Ariana Grande. Grande, a ... will take her to 25 cities across the United States ...
Breaking Medicine News(10 mins):Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 2Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 3Health News:Villa Group Resorts in Cabo Largely Unharmed, Plan to Re-open Early October 2Health News:Villa del Palmar at the Islands of Loreto Fully Functioning After Hurricane 2Health News:Villa del Palmar at the Islands of Loreto Fully Functioning After Hurricane 3Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 2Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 3
... A new comparison of the procedures to help prevent ... of the neck concludes they are equally effective at ... surgery or a minimally invasive treatment using wire coils ... six percent. Results of the analysis were detailed in ...
... blood test to help diagnose major depressive disorder indicates ... a paper published in the journal Molecular Psychiatry ... reports that a test analyzing levels of nine biomarkers ... without significant false-positive results. "Traditionally, ...
... Reinberg HealthDay Reporter , TUESDAY, Jan. 31 ... to control indigestion and heartburn may put themselves at ... use of these drugs, called proton pump inhibitors (PPIs), ... percent for current or former smokers, the researchers added. ...
... you are a people-pleaser who strives to keep your social ... certain social situations like Super Bowl watch parties. A new ... not, some people eat in an attempt to keep others ... upset the sense of social harmony," says Julie Exline, a ...
... TUESDAY, Jan. 31 (HealthDay News) -- Physicians can boost their chances ... flexible sigmoidoscopy test, which is a less invasive procedure than ... at the value of following up a negative flexible sigmoidoscopy test ... repeat test. However, "you don,t find twice as many [signs ...
... new therapies and data on the relative benefits of ... advance of the fourth annual Genitourinary Cancers Symposium, being ... Marquis in San Francisco, Calif. The results of ... briefing via live webcast): 1) Vigorous Exercise Linked ...
Cached Medicine News:Health News:Stents and surgery for blocked neck arteries are neck-and-neck as lasting stroke prevention 2Health News:Stents and surgery for blocked neck arteries are neck-and-neck as lasting stroke prevention 3Health News:Blood test accurately distinguishes depressed patients from healthy controls 2Health News:Blood test accurately distinguishes depressed patients from healthy controls 3Health News:Heartburn Drugs May Raise Fracture Risk in Older Women 2Health News:Heartburn Drugs May Raise Fracture Risk in Older Women 3Health News:Hold the extra burgers and fries when people pleasers arrive 2Health News:Alternative to Colonoscopy Spots Cancers, Too 2Health News:Research from the 2012 Genitourinary Cancers Symposium highlights new treatments, compares existing therapies for prostate cancer 2
(Date:9/20/2014)... , Sept. 20, 2014 /CNW/ - The issue: Mylan Pharmaceuticals ... all lots of its Mylan-Nitro Spray 0.4 mg/metered dose due ... of the pump component. A missing "dip ... nitroglycerin to the patient. This defect may lead patients to ... are unable to access it. Not receiving nitroglycerin could place ...
(Date:9/19/2014)... HILL, N.C. , Sept. 19, 2014 /PRNewswire/ ... role in forging relationships with key opinion leaders ... market and competition. Despite the critical nature of ... created many challenges, including altering the landscape for ... According to research, the oversight responsibility ...
(Date:9/19/2014)... YORK , Sept. 19, 2014 Harwood ... against the board of directors of PDL BioPharma, Inc. ... concerning whether the board has breached its fiduciary duties ... On September 16, 2014, the Company disclosed: "On ... independent registered accounting firm, Ernst & Young LLP ("EY"), ...
Breaking Medicine Technology:Advisory - Mylan Pharmaceuticals recalling nitroglycerin spray due to defective pump 2Role of Medical Science Liaisons Shifting in Healthcare Industry 2Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc. 2
... Ortho Biotech today announced that 12,clinical studies of ... at the 49th annual meeting of the American ... Center on December 8-11,2007., "We are very ... said Craig Tendler, M.D., Vice President, Medical Affairs,Oncology/Nephrology, ...
... Genoptix, Inc. (Nasdaq:,GXDX), a provider of personalized ... Atlanta, Georgia, that it will launch testing for ... expands the Genoptix service,offering for patients with hematomalignancies, ... management. Genoptix believes it will be the first,commercial ...
Cached Medicine Technology:Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting 2Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting 3Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting 4Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting 5Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting 6Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting 7Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting 8Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting 9Genoptix, Inc. Announces Availability of MPL W515 L/K Mutation Analysis for MPD at 49th Annual American Society of Hematology (ASH) Meeting 2Genoptix, Inc. Announces Availability of MPL W515 L/K Mutation Analysis for MPD at 49th Annual American Society of Hematology (ASH) Meeting 3
Research Series 2100 Adjustable-volume Pipette, 2.0-20 l, single-channel with adjustable-volume setting...
... Since 1991 Intersurgical Incorporated ... filters, heat and moisture ... therapy products, hand-held nebulizers ... of accessories and connectors ...
... Intersurgical Incorporated manufactures high ... and moisture exchangers, ventilator ... hand-held nebulizers and an ... and connectors for anesthesia ...
The Pall High Performance HME is a high efficiency heat and moisture exchanger, indicated to protect patients against the potential risks of ventilation with dry and cold gases....
Medicine Products: